Guilan Quan

Laboratoire de Chémo-biologie synthétique et thérapeutique

Publishes on Advancements in Transdermal Drug Delivery, Nanoplatforms for cancer theranostics, Advanced Drug Delivery Systems. 118 papers and 6.3k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#3 Emerging Leader in Advancements in Transdermal Drug Delivery

118Publications

6.3kTotal Citations

#3in Advancements in Transdermal Drug Delivery

First publication: 2012First senior author: 2017

Advancements in Transdermal Drug Delivery Nanoplatforms for cancer theranostics Advanced Drug Delivery Systems Nanoparticle-Based Drug Delivery Antimicrobial Peptides and Activities

Top publicationsby citations

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy

Boyi Niu, Chuanbin Wu, Kaixin Liao et al.|Biomaterials|2021

Cited by 1.1k

Mesoporous silica nanoparticles for drug and gene delivery

Yixian Zhou, Chuanbin Wu, Guilan Quan et al.|Acta Pharmaceutica Sinica B|2018

Cited by 691

Microneedle-mediated transdermal drug delivery for treating diverse skin diseases

Dan Yang, Chuanbin Wu, Minglong Chen et al.|Acta Biomaterialia|2020

Cited by 247

Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era

Liming Lin, Xin Pan, Jiaying Chi et al.|Acta Pharmaceutica Sinica B|2021

Cited by 176

Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array

Shiqi Lin, Chuanbin Wu, Guilan Quan et al.|Journal of Controlled Release|2019

Cited by 153